Getting real with Amy Abernethy on The BioCentury Show
Verily’s president of Clinical Studies Platforms discusses how the company is combining real-world and clinical data to produce actionable evidence
Amy Abernethy has focused her career as an academic researcher, as CMO and CSO at Flatiron Health, as a senior FDA official, and now as president of clinical studies platforms at Verily Life Sciences on making real the vision of a learning healthcare system.
In a conversation with The BioCentury Show, Abernethy described some of the projects Verily is undertaking, as well as its overall strategy. The company, she said, is building systems to combine real-world data with data from clinical trials to answer clinical questions that physicians and patients can act on and that inform medical product development and public health. ...